Document: NUREG-0800
Document ID: c8df76d2-a185-407d-a110-f0bc0fb638ad
Document Type: srp
Title: LIQUID WASTE MANAGEMENT SYSTEMS
Source: NUREG-0800
Source URL: https://www.nrc.gov/docs/ML0523/ML052350102.pdf
Revision Date: 2023-06
Chapter: 11
Section ID: 11.2
CFR Part: 
CFR Title: 

Content:
e met by using the regulatory positions contained in the following regulatory guides listed below. a. Regulatory Guide 1.110 as it relates to performing a cost-benefit analysis for reducing cumulative dose to the population by using available technology. b. Regulatory Guide 1.143 as it relates to the seismic design and quality group classification of components used in the liquid waste treatment system and structures housing systems and the provisions used to control leakages. 5. 10 CFR Part 50, Appendix I, Sections II.A and II.D as it relates to the numerical guides for dose design objectives and limiting conditions for operation to meet the "as low as is reasonably achievable" criterion. The liquid radwaste treatment system should have the capability to meet the requirements specified in 10 CFR Part 20, § 20.106 and 10 CFR Part 50, § 50.34a, and General Design Criteria 60 and 61 of Appendix A of 10 CFR Part 50 and the dose design objectives specified in Sections II.A and II.D of Appendix I to 10 CFR Part 50, including provisions to treat liquid radioactive waste. 1. Specific criteria necessary to meet the relevant requirements of the Commission regulations are as follows: a. The calculated annual total quantity of all radioactive material released from each reactor at the site to unrestricted areas will not result in an estimated annual dose or dose commitment from liquid effluents for any individual in an unrestricted area from all pathways of exposure in excess of 3 millirems to the total body or 10 millirems to any organ. 11.2-3 Rev. 2 - July 1981 b. In addition to l.a above, the liquid radwaste treatment systems should include all items of reasonably demonstrated technology that when added to.the system sequentially and in order of diminishing cost-benefit return, can for a favorable cost-benefit ratio effect reductions in dose to the population reasonably expected to be within 50 miles of the reactor. Regulatory Guide 1.110 provides an accep- table method